Compare MBAI & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBAI | AMS |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | Israel | United States |
| Employees | 85 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 11.1M |
| IPO Year | N/A | 1995 |
| Metric | MBAI | AMS |
|---|---|---|
| Price | $1.44 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.2K | ★ 96.6K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,714,000.00 |
| Revenue This Year | N/A | $6.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.81 |
| 52 Week Low | $1.29 | $1.25 |
| 52 Week High | $3.92 | $3.11 |
| Indicator | MBAI | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.95 | 48.47 |
| Support Level | $1.30 | $1.27 |
| Resistance Level | $1.83 | $2.20 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 27.45 | 34.09 |
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.